News Fuji Pharma Co., Ltd.

Equities

4554

JP3816200004

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-05-15 EDT			5-day change	1st Jan Change
1,529 ^JPY	+0.72%		-4.44%	-12.08%

2023	Mithra Pharmaceuticals' License Partner Files for Estelle's Marketing Approval in Japan; Shares Jump	MT
2023	Alvotech Partner Secures Marketing Approval for Stelara Biosimilar AVT04 in Japan	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Ex-dividend day for interim dividend	03-27	FA
Mithra Pharmaceuticals' License Partner Files for Estelle's Marketing Approval in Japan; Shares Jump	23-10-23	MT
Final dividend	23-09-27	FA
Alvotech Partner Secures Marketing Approval for Stelara Biosimilar AVT04 in Japan	23-09-25	MT
Alvotech, Fuji Pharma Win Marketing Approval in Japan for Stelara Biosimilar	23-09-25	MT
Vistagen and Fuji Enter Exclusive Negotiation Agreement for a Potential License to Develop and Commercialize Vistagen's Investigational Menopausal Hot Flash Therapy, PH80 Nasal Spray, in Japan	23-09-06	AQ
Vistagen Therapeutics, Fuji Pharma Sign Exclusive Negotiation Deal for Japanese Market	23-09-05	MT
Vistagen and Fuji Pharma Co., Ltd. Enter Exclusive Negotiation Agreement for Potential License to Develop and Commercialize Vistagen?s Investigational Menopausal Hot Flash Therapy, PH80 Nasal Spray, in Japan	23-09-05	CI
Lotus Pharmaceutical Co., Ltd. and Fuji Pharma Co., Ltd. Joint Product Receives the Approval for Lenalidomide Capsules,2.5 Mg and 5 Mg from the Japan Pmda	23-08-15	CI
Mithra Receives Milestone Payment from Fuji Pharma; Shares Surge 11%	23-08-03	MT
Fuji Pharma Co., Ltd. Reports Earnings Results for the Half Year Ended March 31, 2023	23-05-11	CI
Ex-dividend day for interim dividend	23-03-29	FA
Sector Update: Health Care Stocks Mixed Pre-Bell Friday	23-01-13	MT
Alvotech, Fuji Pharma Include New Biosimilar Candidate in Marketing Partnership in Japan	23-01-13	MT
Alvotech and Fuji Pharma Expand Partnership Adding a New Biosimilar Candidate	23-01-13	AQ
Alvotech and Fuji Pharma Expands Partnership Adding A New Biosimilar Candidate	23-01-13	CI
Mithra and Fuji announce approval of NEXTSTELLIS in Thailand	22-10-24	AQ
Alvotech Says Partner Fuji Pharma Submitted Application for Marketing Approval of Biosimilar Candidate in Japan	22-10-17	MT
Fuji Pharma Co., Ltd. Submits Application for Marketing Approval of First Biosimilar Candidate in Japan	22-10-17	CI
Ex-dividend day for final dividend	22-09-28	FA

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Fuji Pharma Co., Ltd.

Equities

4554

JP3816200004

Summary

Filters